CCM NYSE
Concord Medical Services Holdings Limited
1W: -16.4%
1M: -35.3%
3M: -35.7%
YTD: -29.5%
1Y: -51.0%
3Y: -78.2%
5Y: -89.8%
$3.17
+0.23 (+7.82%)
Weekly Expected Move ±10.0%
$2
$3
$3
$3
$4
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Revenue Segmentation
By Product / Service
By Geography
Revenue by Segment (5-Year Trend)
Income Trends
Revenue
$384M
-28.6% ▼
5Y CAGR: +14.1%
Gross Profit
-$79M
-3.3% ▼
Operating Income
-$532M
-14.9% ▼
Net Income
-$308M
-3.6% ▼
EPS (Diluted)
$-2116.80
-3.6% ▼
EBITDA
-$346M
-0.4% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $223M | $486M | $472M | $537M | $384M |
| YoY Growth | +12.4% | +117.8% | -2.8% | +13.8% | -28.6% |
| Cost of Revenue | $210M | $543M | $624M | $614M | $463M |
| Gross Profit | $13M | -$57M | -$152M | -$77M | -$79M |
| Gross Margin | 5.9% | -11.7% | -32.3% | -14.3% | -20.6% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $321M | $401M | $373M | $386M | $453M |
| Operating Expenses | $329M | $401M | $373M | $386M | $453M |
| Operating Income | -$316M | -$458M | -$525M | -$463M | -$532M |
| Operating Margin | -141.7% | -94.4% | -111.2% | -86.2% | -138.6% |
| Interest Expense | $81M | $74M | $120M | $166M | $193M |
| Income Before Tax | -$442M | -$529M | -$840M | -$556M | -$670M |
| Tax Expense | -$38M | -$7M | -$71M | -$25M | -$18M |
| Net Income | -$310M | -$271M | -$490M | -$298M | -$308M |
| Net Margin | -139.0% | -55.9% | -103.7% | -55.4% | -80.3% |
| EPS (Diluted) | $-4600.50 | $-5635.50 | $-3362.70 | $-2044.20 | $-2116.80 |
| EBITDA | -$237M | -$364M | -$402M | -$344M | -$346M |
| Shares Outstanding | 145600 | 145600 | 145600 | 145600 | 145600 |